<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04822610</url>
  </required_header>
  <id_info>
    <org_study_id>2020/1562</org_study_id>
    <nct_id>NCT04822610</nct_id>
  </id_info>
  <brief_title>Comparison of Interscalene Block and Suprascapular With Axillary Block</brief_title>
  <official_title>Comparison of Analgesic Effectiveness of Ultrasound Guided Interscalene Block Versus Suprascapular With Axillary Block in Shoulder Arthroplasties</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Istanbul University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Istanbul University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      In this study, the investigators are going to compare the analgesia effectiveness of&#xD;
      interscalane block and suprascapular with axillary block in shoulder arthroplasties&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In the preoperative period, the participants will be taken to the block room. The&#xD;
      participants will be monitored, standard sedation will be applied.&#xD;
&#xD;
      The first group will be get interscalene block. The second group will be get suprascapular&#xD;
      and axillary block. The third group patient will be get no block. Afterwards, the&#xD;
      participants will be operated under general anesthesia. A patient-controlled analgesia device&#xD;
      will be attached to each group of participants and their postoperative follow-up will be&#xD;
      made.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 30, 2021</start_date>
  <completion_date type="Anticipated">November 30, 2021</completion_date>
  <primary_completion_date type="Anticipated">November 20, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Study group - Study group- Control group</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
    <masking_description>open</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Opioid (mg) consumption</measure>
    <time_frame>48 hours</time_frame>
    <description>Opioid (mg) consumption</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Measurement of postoperative pain</measure>
    <time_frame>48 hours</time_frame>
    <description>VAS (visual analog scale) (0: no pain, 10: the worst pain imaginable)</description>
  </primary_outcome>
  <other_outcome>
    <measure>Operation time</measure>
    <time_frame>during surgery</time_frame>
    <description>minutes</description>
  </other_outcome>
  <other_outcome>
    <measure>Hospital stay</measure>
    <time_frame>postoperative period up to 3 days</time_frame>
    <description>days</description>
  </other_outcome>
  <other_outcome>
    <measure>Postoperatif complication</measure>
    <time_frame>postoperative period up to 3 days</time_frame>
    <description>yes-no</description>
  </other_outcome>
  <other_outcome>
    <measure>Patient satisfaction</measure>
    <time_frame>postoperative period up to 3 days</time_frame>
    <description>5-point Likert scale: very satisfied (= 5), relatively satisfied (= 4), fairly satisfied (= 3), relatively dissatisfied (= 2) and very dissatisfied (= 1)</description>
  </other_outcome>
  <other_outcome>
    <measure>Beck Depression Inventory (BDI)</measure>
    <time_frame>Will be done 3 times 1- on pre-operative hospitalization 2- in the hospital after surgery 3- in the 1st month follow-up after surgery</time_frame>
    <description>0-9: indicates minimal depression 10-18: indicates mild depression 19-29: indicates moderate depression 30-63: indicates severe depression.</description>
  </other_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">76</enrollment>
  <condition>Shoulder Arthroplasty</condition>
  <condition>Ultrasound Guided</condition>
  <arm_group>
    <arm_group_label>Study group: interscalene block + IV PCA</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>preop usg guided interscalene block and IV PCA</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Study group: suprascapular block + axillary block + IV PCA</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>preop usg guided suprascapular block + axillary block and IV PCA</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group: IV PCA</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>no block + IV PCA</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>interscalene block</intervention_name>
    <description>peripheral nerve block</description>
    <arm_group_label>Study group: interscalene block + IV PCA</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>suprascapular block + axillary block</intervention_name>
    <description>peripheral nerve block</description>
    <arm_group_label>Study group: suprascapular block + axillary block + IV PCA</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  accepting the study protocol,&#xD;
&#xD;
          -  age older than 18 years and younger than 90 years,&#xD;
&#xD;
          -  undergoing shoulder arthroplasty surgery&#xD;
&#xD;
          -  the American Society of Anesthesiologist (ASA) physical status of I-II-III-IV&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  severe respiratory distress&#xD;
&#xD;
          -  patients with local anesthetic allergy&#xD;
&#xD;
          -  contralateral hemidiaphragmatic parrhesia&#xD;
&#xD;
          -  recurrent laryngeal nerve palsy&#xD;
&#xD;
          -  infection at the injection site&#xD;
&#xD;
          -  coagulation disorder&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kübra Ozkan, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Istanbul Unıversity, Istanbul Faculty of Medicine, Anesthesiology</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Nur Canbolat, MD</last_name>
    <phone>+905325162583</phone>
    <email>drnurekiz@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Mehmet Büget, Assoc. Prof</last_name>
    <phone>+905324133282</phone>
    <email>mbuget@yahoo.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Istanbul University, Faculty of Medicine</name>
      <address>
        <city>Istanbul</city>
        <state>Fatih</state>
        <zip>34093</zip>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nur Canbolat, MD</last_name>
      <email>drnurekiz@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Mehmet I. Buget, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Nur Canbolat, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Kubra Ozkan, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <reference>
    <citation>Toma O, Persoons B, Pogatzki-Zahn E, Van de Velde M, Joshi GP; PROSPECT Working Group collaborators. PROSPECT guideline for rotator cuff repair surgery: systematic review and procedure-specific postoperative pain management recommendations. Anaesthesia. 2019 Oct;74(10):1320-1331. doi: 10.1111/anae.14796. Epub 2019 Aug 7.</citation>
    <PMID>31392721</PMID>
  </reference>
  <reference>
    <citation>Lee SM, Park SE, Nam YS, Han SH, Lee KJ, Kwon MJ, Ji JH, Choi SK, Park JS. Analgesic effectiveness of nerve block in shoulder arthroscopy: comparison between interscalene, suprascapular and axillary nerve blocks. Knee Surg Sports Traumatol Arthrosc. 2012 Dec;20(12):2573-8. doi: 10.1007/s00167-012-1950-5. Epub 2012 Mar 21.</citation>
    <PMID>22434159</PMID>
  </reference>
  <reference>
    <citation>Park JY, Bang JY, Oh KS. Blind suprascapular and axillary nerve block for post-operative pain in arthroscopic rotator cuff surgery. Knee Surg Sports Traumatol Arthrosc. 2016 Dec;24(12):3877-3883. Epub 2016 Jan 5.</citation>
    <PMID>26733274</PMID>
  </reference>
  <reference>
    <citation>Cho N, Kang RS, McCartney CJL, Pawa A, Costache I, Rose P, Abdallah FW. Analgesic benefits and clinical role of the posterior suprascapular nerve block in shoulder surgery: a systematic review, meta-analysis and trial sequential analysis. Anaesthesia. 2020 Mar;75(3):386-394. doi: 10.1111/anae.14858. Epub 2019 Oct 3.</citation>
    <PMID>31583679</PMID>
  </reference>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>January 19, 2021</study_first_submitted>
  <study_first_submitted_qc>March 29, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">March 30, 2021</study_first_posted>
  <last_update_submitted>November 18, 2021</last_update_submitted>
  <last_update_submitted_qc>November 18, 2021</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 19, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Istanbul University</investigator_affiliation>
    <investigator_full_name>Nur Canbolat</investigator_full_name>
    <investigator_title>Principal Investigator, M.D.</investigator_title>
  </responsible_party>
  <keyword>axillary block</keyword>
  <keyword>suprascapular block</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

